CN103381235B - Traditional Chinese medicine for treatment of hyperosteogeny and spondylopathy - Google Patents
Traditional Chinese medicine for treatment of hyperosteogeny and spondylopathy Download PDFInfo
- Publication number
- CN103381235B CN103381235B CN201310284497.XA CN201310284497A CN103381235B CN 103381235 B CN103381235 B CN 103381235B CN 201310284497 A CN201310284497 A CN 201310284497A CN 103381235 B CN103381235 B CN 103381235B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- spondylopathy
- chinese medicine
- hyperosteogeny
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treatment of hyperosteogeny and spondylopathy, and especially for treatment of cervical spondylosis. The traditional Chinese medicine comprises the following crude drugs by weight: radix angelicae pubescentis, radix clematidis, Caulis Erycibes, Tripterygium wilfordii, crude Sichuan aconite roots, Stigma Croci, pleione rhizome, Knoxia valerianoides Thorel ex Pitard, Chinese redbud bark, rhubarb, Xu Changqing, ground beetles, frankincense, myrrh, gleditsia sinensis, dipsacus roots, Chinese prickly ash, camphor and white spirit. The traditional Chinese medicine can effectively solve the problems of slow curative effect, easy relapse, undesirable effect, high risk, expensive cost, great trauma, long recovery period and easy recurrence during treatment of hyperosteogeny and spondylopathy. With obvious curative effects on hyperosteogeny and spondylopathy, the traditional Chinese medicine can alleviate symptoms and improve functions at the earlier stage, and at the later stage, can enhance the muscle tension, improve and correct abnormal functions, as well as strengthen ligament elasticity.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of hyperosteogeny and spondylopathy, be used in particular for the Chinese medicine of the treatment of cervical spondylosis.
Background technology
Hyperosteogeny is a kind of frequently-occurring disease, commonly encountered diseases.Bone matrix hyperplasia is commonly encountered diseases, the frequently-occurring disease of person in middle and old age, external main called after osteoarthritis, osteoarthritis, hyperplastic osteoarthritis, degeneration osteoarthritis.The main name of China's medical science has osteoarthritis, intervertebral disc degeneration, proliferative arthritis, osteoarthrosis degenerative disease, bony spur etc., and motherland's medical science then belongs to the scope of arthromyodynia.
Spondylopathy is exactly sclerotin, intervertebral disc, ligament, the muscle generation pathological changes of vertebra, and then compressing, traction stimulate spinal cord, spinal nerves, blood vessel, vegetative nerve thus occur complicated and diversified symptom.Commonly encountered diseases kind is cervical spondylosis, lumbar spondylosis.Cardinal symptom: can not uprightly, headache, dizzy, blurred vision, hypomnesis, neck shoulder ache, inappetence, regurgitation, vomiting, weakness of the lower extremities, severe patient may cause paralysis.
Spondylopathy is divided into following five types usually, and 1, neck type (pure): X-ray film display position, cervical vertebra side physiologic radian disappears and the performance of articular process slur.2, spondylotic radiculopathy: cervical X-ray sheet normotopia shows uncovertebral joint regression hypertrophy, position, side display cervical curvature changes, as physiology lordosis reduces, to disappear or in back-flexing.Pathological interspinal gap narrows.Loxosis display intervertebral foramina diminishes.3, myeloid form: the visible typical cervical spondylosis of X-ray film changes.Myelography lesions showed vertebral disc portion in L " or " U " shape video.4, vertebral artery type: x-ray plain film visible uncovertebral joint hypertrophy, the visible vertebral artery of vertebral arteriography be tortuous, attenuate and oppress phenomenon.Five, adrenergic type: X-ray film has typical cervical spondylosis to change
The treatment of hyperosteogeny and spondylopathy, often adopts oral drug therapy at present, and traction and massaging is treated, and physical therapy, but the treatment of above traditional method, curative effect is slow, and easily occur repeatedly, weak effect, operation also can be adopted to treat, but risk is high, the expense eighteenth of the twenty is expensive, and wound is large, and convalescent period is long, easily recurs.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine for the treatment of hyperosteogeny and spondylopathy, when effectively can solve treatment hyperosteogeny and spondylopathy, curative effect is slow, and easily occur repeatedly, weak effect, risk is high, and the expense eighteenth of the twenty is expensive, and wound is large, the problem of convalescent period long and easily recurrence.
Treat a Chinese medicine for hyperosteogeny and spondylopathy, be made up, according to parts by weight of following crude drug: Radix Angelicae Pubescentis 8-10 part, Radix Clematidis 9-11 part, Caulis Erycibes 3-5 part, Radix Tripterygii Wilfordii 3-5 part, Radix Aconiti 3-5 part, Stigma Croci 4-6 part, Pseudobulbus Cremastrae Seu Pleiones 4-6 part, Knoxia valerianoides 4-6 part, Cortex cercis chinensis 5-8 part, Radix Et Rhizoma Rhei 4-6 part, Radix Cynanchi Paniculati 8-10 part, eupolyphaga 3-5 part, Olibanum 10 parts, Myrrha 9-11 part, Fructus Gleditsia 3-5 part, Radix Dipsaci 9-11 part, Pericarpium Zanthoxyli 9-11 part, Camphora 3-5 part, Chinese liquor 400-600 part.
Treat a Chinese medicine for hyperosteogeny and spondylopathy, be made up, according to parts by weight of following crude drug: Radix Angelicae Pubescentis 8-10 part, Radix Clematidis 10 parts, Caulis Erycibes 3-5 part, Radix Tripterygii Wilfordii 3-5 part, Radix Aconiti 3-5 part, Stigma Croci 5 parts, Pseudobulbus Cremastrae Seu Pleiones 5 parts, Knoxia valerianoides 5 parts, Cortex cercis chinensis 5-8 part, Radix Et Rhizoma Rhei 5 parts, Radix Cynanchi Paniculati 8-10 part, eupolyphaga 3-5 part, Olibanum 10 parts, Myrrha 10 parts, Fructus Gleditsia 3-5 part, Radix Dipsaci 10 parts, 10 parts, Pericarpium Zanthoxyli, Camphora 3-5 part, Chinese liquor 500 parts.
Treat a Chinese medicine for hyperosteogeny and spondylopathy, be made up, according to parts by weight of following crude drug: Radix Angelicae Pubescentis 8 parts, Radix Clematidis 9 parts, Caulis Erycibes 3 parts, Radix Tripterygii Wilfordii 3 parts, Radix Aconiti 3 parts, Stigma Croci 4 parts, Pseudobulbus Cremastrae Seu Pleiones 4 parts, Knoxia valerianoides-5 parts, Cortex cercis chinensis 5 parts, Radix Et Rhizoma Rhei 4 parts, Radix Cynanchi Paniculati 8 parts, eupolyphaga 3 parts, Olibanum 9 parts, Myrrha 9 parts, 3 parts, Fructus Gleditsia, Radix Dipsaci 9 parts, 9 parts, Pericarpium Zanthoxyli, Camphora 3 parts, Chinese liquor 400 parts.
Treat a Chinese medicine for hyperosteogeny and spondylopathy, be made up, according to parts by weight of following crude drug: Radix Angelicae Pubescentis 9 parts, Radix Clematidis 10 parts, Caulis Erycibes 4 parts, Radix Tripterygii Wilfordii 4 parts, Radix Aconiti 4 parts, Stigma Croci 5 parts, Pseudobulbus Cremastrae Seu Pleiones 5 parts, Knoxia valerianoides 5 parts, Cortex cercis chinensis 6 parts, Radix Et Rhizoma Rhei 5 parts, Radix Cynanchi Paniculati 9 parts, eupolyphaga 4 parts, Olibanum 10 parts, Myrrha 10 parts, 4 parts, Fructus Gleditsia, Radix Dipsaci 10 parts, 10 parts, Pericarpium Zanthoxyli, Camphora 4 parts, Chinese liquor 500 parts.
Treat a Chinese medicine for hyperosteogeny and spondylopathy, be made up, according to parts by weight of following crude drug: Radix Angelicae Pubescentis 10 parts, Radix Clematidis 11 parts, Caulis Erycibes 5 parts, Radix Tripterygii Wilfordii 5 parts, Radix Aconiti 5 parts, Stigma Croci 6 parts, Pseudobulbus Cremastrae Seu Pleiones 6 parts, Knoxia valerianoides 6 parts, Cortex cercis chinensis 8 parts, Radix Et Rhizoma Rhei 6 parts, Radix Cynanchi Paniculati 10 parts, eupolyphaga 5 parts, Olibanum 11 parts, Myrrha 11 parts, 5 parts, Fructus Gleditsia, Radix Dipsaci 11 parts, 11 parts, Pericarpium Zanthoxyli, Camphora 5 parts, Chinese liquor 600 parts.
Treating a Chinese medicine for hyperosteogeny and spondylopathy, be made up of following steps, is more than 60 ° soaking in Chinese liquor 7 days by medicinal for above-mentioned raw materials temperature, filters, removes slag, obtain filtrate.
Beneficial effect of the present invention and advantage as follows:
1, the Chinese herbal medicine that the present invention selects meets " pharmacopeia " regulation, and reasonable recipe, without obvious toxic-side effects.
2, medicine of the present invention, has obvious curative effects for hyperosteogeny and spondylopathy, and early stage, relief of symptoms, improved function, and the later stage improves muscle tone, improves and corrects abnormal function, strengthening ligament elasticity powerful.
3, the present invention makes simply, easy to use, cheap.
Medicine composition of the present invention: Radix Angelicae Pubescentis wind-expelling pain-stopping, Radix Clematidis expelling wind and removing dampness, removing obstruction in the collateral to relieve pain, expectorant water, the loose hypochondriac lump, Caulis Erycibes expelling wind and dampness, relaxing muscles and tendons and activating QI and blood in the collateral, detumescence, pain relieving, Radix Tripterygii Wilfordii is dispeled the wind, removing toxic substances, parasite killing, Radix Aconiti expelling wind and removing dampness, antalgic, Stigma Croci blood circulation promoting and blood stasis dispelling, dispersing stagnation and relieving accumulation of pathogens, pain relieving, Pseudobulbus Cremastrae Seu Pleiones heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, Knoxia valerianoides is let out internal organs water and is wet and effect of diuresis, Cortex cercis chinensis controls bones and muscles pain, and phlegm-fire flaccidity is soft, the dampness tuberculosis of bone and joint, and Radix Et Rhizoma Rhei is attacked stagnant; Clearing away damp-heat; Pathogenic fire purging; Removing heat from blood; Blood stasis dispelling; Removing toxic substances, Radix Cynanchi Paniculati eases pain, cough-relieving, inducing diuresis to remove edema, promoting blood circulation and detoxication, eupolyphaga controls blood stasis, injured, and Olibanum is invigorated blood circulation, circulation of qi promoting, pain relieving, Myrrha is invigorated blood circulation, silt of dispelling, stimulate the menstrual flow, effect of pain relieving, Fructus Gleditsia heat clearing away, dampness removing, harness the river swollen, pyretic stranguria, hot urination, the synthetism of teasel folding, the stomach invigorating of Pericarpium Zanthoxyli fragrance, warming spleen and stomach for dispelling cold, removing damp and stopping pain, parasite killing removing toxic substances, antipruritic solution raw meat, Camphora parasite killing, except scabies, treat sore due to scald and burn, enemy's oxious gas; The effects such as Chinese liquor energy relaxing muscles and tendons to promote blood circulation, pain relieving, hemostasis, are easy to disperse, can strengthen the property of medicine.Stigma Croci, Radix Tripterygii Wilfordii are monarch drug, and Radix Aconiti, Fructus Gleditsia, eupolyphaga are ministerial drug, and Radix Angelicae Pubescentis, Radix Clematidis, Caulis Erycibes, Pseudobulbus Cremastrae Seu Pleiones, Knoxia valerianoides are adjuvant drug, and Radix Cynanchi Paniculati, Olibanum, Myrrha, Radix Dipsaci, Pericarpium Zanthoxyli, Camphora are for making medicine.
Detailed description of the invention
Following examples and embodiment are to further illustrate the present invention, instead of restriction the present invention.
Treat a Chinese medicine for hyperosteogeny and spondylopathy, be made up of following crude drug: Radix Angelicae Pubescentis 8-10g, Radix Clematidis 9-11 g, Caulis Erycibes 3-5 g, Radix Tripterygii Wilfordii 3-5 g, Radix Aconiti 3-5 g, Stigma Croci 4-6 g, Pseudobulbus Cremastrae Seu Pleiones 4-6 g, Knoxia valerianoides 4-6 g, Cortex cercis chinensis 5-8 g, Radix Et Rhizoma Rhei 4-6 g, Radix Cynanchi Paniculati 8-10 g, eupolyphaga 3-5 g, Olibanum 10 g, Myrrha 9-11 g, Fructus Gleditsia 3-5 g, Radix Dipsaci 9-11 g, Pericarpium Zanthoxyli 9-11 g, Camphora 3-5 g, Chinese liquor 400-600 g.
Treat a Chinese medicine for hyperosteogeny and spondylopathy, be made up of following crude drug: Radix Angelicae Pubescentis 8-10 g, Radix Clematidis 10 g, Caulis Erycibes 3-5 g, Radix Tripterygii Wilfordii 3-5 g, Radix Aconiti 3-5 g, Stigma Croci 5 g, Pseudobulbus Cremastrae Seu Pleiones 5 g, Knoxia valerianoides 5 g, Cortex cercis chinensis 5-8 g, Radix Et Rhizoma Rhei 5 g, Radix Cynanchi Paniculati 8-10 g, eupolyphaga 3-5 g, Olibanum 10 g, Myrrha 10 g, Fructus Gleditsia 3-5 g, Radix Dipsaci 10 g, Pericarpium Zanthoxyli 10 g, Camphora 3-5 g, Chinese liquor 500 g.
Treat a Chinese medicine for hyperosteogeny and spondylopathy, be made up of following crude drug: Radix Angelicae Pubescentis 8 g, Radix Clematidis 9 g, Caulis Erycibes 3 g, Radix Tripterygii Wilfordii 3 g, Radix Aconiti 3 g, Stigma Croci 4 g, Pseudobulbus Cremastrae Seu Pleiones 4 g, Knoxia valerianoides-5 g, Cortex cercis chinensis 5 g, Radix Et Rhizoma Rhei 4 g, Radix Cynanchi Paniculati 8 g, eupolyphaga 3 g, Olibanum 9 g, Myrrha 9 g, Fructus Gleditsia 3 g, Radix Dipsaci 9 g, Pericarpium Zanthoxyli 9 g, Camphora 3 g, Chinese liquor 400 g.
Treat a Chinese medicine for hyperosteogeny and spondylopathy, be made up of following crude drug: Radix Angelicae Pubescentis 9g, Radix Clematidis 10g, Caulis Erycibes 4g, Radix Tripterygii Wilfordii 4g, Radix Aconiti 4g, Stigma Croci 5g, Pseudobulbus Cremastrae Seu Pleiones 5g, Knoxia valerianoides 5g, Cortex cercis chinensis 6g, Radix Et Rhizoma Rhei 5g, Radix Cynanchi Paniculati 9g, eupolyphaga 4g, Olibanum 10g, Myrrha 10g, Fructus Gleditsia 4g, Radix Dipsaci 10g, Pericarpium Zanthoxyli 10g, Camphora 4g, Chinese liquor 500g.
Treat a Chinese medicine for hyperosteogeny and spondylopathy, be made up of following crude drug: Radix Angelicae Pubescentis 10g, Radix Clematidis 11g, Caulis Erycibes 5g, Radix Tripterygii Wilfordii 5g, Radix Aconiti 5g, Stigma Croci 6g, Pseudobulbus Cremastrae Seu Pleiones 6g, Knoxia valerianoides 6g, Cortex cercis chinensis 8g, Radix Et Rhizoma Rhei 6g, Radix Cynanchi Paniculati 10g, eupolyphaga 5g, Olibanum 11g, Myrrha 11g, Fructus Gleditsia 5g, Radix Dipsaci 11g, Pericarpium Zanthoxyli 11g, Camphora 5g, Chinese liquor 600g.
Treating a Chinese medicine for hyperosteogeny and spondylopathy, be made up of following steps, is more than 60 ° soaking in Chinese liquor 7 days by medicinal for above-mentioned raw materials temperature, filters, removes slag, obtain filtrate.
Reasonable recipe of the present invention, science, has invigorating blood circulation what, and expelling wind and removing dampness, promoting the flow of QI in the collateral by warming the meridian, clearance are had one's ideas straightened out, effect of dispersing swelling and dissipating binds, dispersing cold for relieving pain, and achieve good effect through clinical practice, and concrete test situation is as follows:
One, diagnostic criteria: hyperosteogeny often sends out position at lumbar vertebra and cervical vertebra, points, kneed symptom is then more rare.Its symptom of hypertrophy occurring in cervical vertebra, at head and upper limb, is shown in again many with upper limb.This position of cervical vertebra does not have manifest symptom, and upper limb symptom is obvious.General hyperplasia is not certain side (be a left side be exactly right), can occur side from shoulder joint to upper arm, underarm connects pain, swollen, the picotement of an intramuscular line of finger, the muscle sites pain that hyperosteogeny patient occurs, ache, fiber crops are swollen, it is light when time is heavy, the course of disease is long, does not heal for many years, more and more heavier.
Spondylopathy is exactly sclerotin, intervertebral disc, ligament, the muscle generation pathological changes of vertebra, and then compressing, traction stimulate spinal cord, spinal nerves, blood vessel, vegetative nerve thus occur complicated and diversified symptom.Commonly encountered diseases kind is cervical spondylosis, lumbar spondylosis.Cardinal symptom: can not uprightly, headache, dizzy, blurred vision, hypomnesis, neck shoulder ache, inappetence, regurgitation, vomiting, weakness of the lower extremities, severe patient may cause paralysis.
Above symptom all can be used as the standard selecting case.
Two, therapeutic scheme: Chinese medicine of the present invention uses 50ml to be applied to affected part at every turn, 2 times on the one; Within 45 days, be a course for the treatment of, after three courses for the treatment of, add up curative effect.
Three, efficacy assessment standard
Cure: freedom of movement, without pain, transference cure, on life, work, study and work without impact.
Effective: symptom is improved, but work, study can be adhered to, need continual cure.
Invalid: symptom is without improvement, and without there being positive effect, medication and not medication indistinction, without the sensation of any alleviation.
Four, add up: clinical in 1200 routine patient's application, undertaken by above-mentioned therapeutic scheme, be summarized as follows:
Lumbar vertebra hyperosteogeny patient 161 people, cures 30 people, effective 124 people, invalid 7 people, and total effective rate reaches 96%; Hyperosteogeny of cervical vertebra patient 347 people, cures 51 people, effective 286 people, invalid 10 people, and total effective rate reaches 97%; Cervical spondylosis 474 people, cures 53 people, effective 405 people, invalid 16 people, and total effective rate reaches 97%; Lumbar spondylosis 218 people, cures 24 people, effective 186 people, invalid 8 people, and total effective rate reaches 96%;
At above treatments period, without any untoward reaction, and visited after 1 year, there are no recurrence after healing.
Efficacy stability of the present invention, easy to use, total effective rate reaches 99%, that one on Chinese medicine is innovated greatly, and determine a difficult problem for current medical circle, hyperosteogeny and spondylopathy are current commonly encountered diseases, easily fall ill, and be difficult to cure, easily repeatedly, people's problems in the urgent need to address always, the present invention has huge economic benefit, Chinese medicine decapacitation treatment hyperosteogeny of the present invention and spondylopathy part, also adapt to traumatic injury, neck-shoulder pain, lumbago and leg pain, the diseases such as numb limbs and tense tendons, after the treatment of 15 days is carried out to 120 traumatic injury patients (fracture forecloses), cure 87 people, effective 32 people, invalid 1 people, total effective rate 99%.The present invention also can coordinate smoked processing, effect is more remarkable, take effect faster, the present invention coordinates and smoked process its warm Du Keda and organize deep, make organization softening, this warm stimulation infiltration, make skin that the effective elements of the medicine in the present invention is absorbed in tissue, eliminate the muscle spasm of diseased region, alleviate inflammatory reaction, improve local microcirculation, activate cell functions and produce heat, strengthen local energy, pass through neural reflex, Humoral immunity, remove metabolite, thus reach the object of curing disease, for painful area, all single hole can be selected, diplopore, three hole moxibustion boxes, outer wiping Chinese medicine of the present invention is in diseased region, executing in the process of processing, every 20 minutes, embrocate a present invention, feel that slight fever is for degree with patient, warp is to 147 patient treatments, treatment cycle shortens 2-3 month than treatment cycle when only embrocating of the present invention.
Claims (6)
1. treat a Chinese medicine for hyperosteogeny and spondylopathy, it is characterized in that, be made up, according to parts by weight of following crude drug: Radix Angelicae Pubescentis 8-10 part, Radix Clematidis 9-11 part, Caulis Erycibes 3-5 part, Radix Tripterygii Wilfordii 3-5 part, Radix Aconiti 3-5 part, Stigma Croci 4-6 part, Pseudobulbus Cremastrae Seu Pleiones 4-6 part, Knoxia valerianoides 4-6 part, Cortex cercis chinensis 5-8 part, Radix Et Rhizoma Rhei 4-6 part, Radix Cynanchi Paniculati 8-10 part, eupolyphaga 3-5 part, Olibanum 10 parts, Myrrha 9-11 part, Fructus Gleditsia 3-5 part, Radix Dipsaci 9-11 part, Pericarpium Zanthoxyli 9-11 part, Camphora 3-5 part, Chinese liquor 400-600 part.
2. the Chinese medicine for the treatment of hyperosteogeny according to claim 1 and spondylopathy, is characterized in that, is made up, according to parts by weight of following crude drug: Radix Angelicae Pubescentis 8-10 part, Radix Clematidis 10 parts, Caulis Erycibes 3-5 part, Radix Tripterygii Wilfordii 3-5 part, Radix Aconiti 3-5 part, Stigma Croci 5 parts, Pseudobulbus Cremastrae Seu Pleiones 5 parts, Knoxia valerianoides 5 parts, Cortex cercis chinensis 5-8 part, Radix Et Rhizoma Rhei 5 parts, Radix Cynanchi Paniculati 8-10 part, eupolyphaga 3-5 part, Olibanum 10 parts, Myrrha 10 parts, Fructus Gleditsia 3-5 part, Radix Dipsaci 10 parts, 10 parts, Pericarpium Zanthoxyli, Camphora 3-5 part, Chinese liquor 500 parts.
3. the Chinese medicine for the treatment of hyperosteogeny according to claim 1 and spondylopathy, is characterized in that, is made up, according to parts by weight of following crude drug: Radix Angelicae Pubescentis 8 parts, Radix Clematidis 9 parts, Caulis Erycibes 3 parts, Radix Tripterygii Wilfordii 3 parts, Radix Aconiti 3 parts, Stigma Croci 4 parts, Pseudobulbus Cremastrae Seu Pleiones 4 parts, Knoxia valerianoides-5 parts, Cortex cercis chinensis 5 parts, Radix Et Rhizoma Rhei 4 parts, Radix Cynanchi Paniculati 8 parts, eupolyphaga 3 parts, Olibanum 9 parts, Myrrha 9 parts, 3 parts, Fructus Gleditsia, Radix Dipsaci 9 parts, 9 parts, Pericarpium Zanthoxyli, Camphora 3 parts, Chinese liquor 400 parts.
4. the Chinese medicine for the treatment of hyperosteogeny according to claim 1 and spondylopathy, is characterized in that, is made up, according to parts by weight of following crude drug: Radix Angelicae Pubescentis 9 parts, Radix Clematidis 10 parts, Caulis Erycibes 4 parts, Radix Tripterygii Wilfordii 4 parts, Radix Aconiti 4 parts, Stigma Croci 5 parts, Pseudobulbus Cremastrae Seu Pleiones 5 parts, Knoxia valerianoides 5 parts, Cortex cercis chinensis 6 parts, Radix Et Rhizoma Rhei 5 parts, Radix Cynanchi Paniculati 9 parts, eupolyphaga 4 parts, Olibanum 10 parts, Myrrha 10 parts, 4 parts, Fructus Gleditsia, Radix Dipsaci 10 parts, 10 parts, Pericarpium Zanthoxyli, Camphora 4 parts, Chinese liquor 500 parts.
5. the Chinese medicine for the treatment of hyperosteogeny according to claim 1 and spondylopathy, is characterized in that, is made up, according to parts by weight of following crude drug: Radix Angelicae Pubescentis 10 parts, Radix Clematidis 11 parts, Caulis Erycibes 5 parts, Radix Tripterygii Wilfordii 5 parts, Radix Aconiti 5 parts, Stigma Croci 6 parts, Pseudobulbus Cremastrae Seu Pleiones 6 parts, Knoxia valerianoides 6 parts, Cortex cercis chinensis 8 parts, Radix Et Rhizoma Rhei 6 parts, Radix Cynanchi Paniculati 10 parts, eupolyphaga 5 parts, Olibanum 11 parts, Myrrha 11 parts, 5 parts, Fructus Gleditsia, Radix Dipsaci 11 parts, 11 parts, Pericarpium Zanthoxyli, Camphora 5 parts, Chinese liquor 600 parts.
6. the Chinese medicine for the treatment of hyperosteogeny according to claim 1 and spondylopathy, is characterized in that, be made up of following steps, is more than 60 ° soaking in Chinese liquor 7 days by medicinal for above-mentioned raw materials temperature, filters, removes slag, obtain filtrate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310284497.XA CN103381235B (en) | 2013-07-09 | 2013-07-09 | Traditional Chinese medicine for treatment of hyperosteogeny and spondylopathy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310284497.XA CN103381235B (en) | 2013-07-09 | 2013-07-09 | Traditional Chinese medicine for treatment of hyperosteogeny and spondylopathy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103381235A CN103381235A (en) | 2013-11-06 |
| CN103381235B true CN103381235B (en) | 2015-04-01 |
Family
ID=49489302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310284497.XA Active CN103381235B (en) | 2013-07-09 | 2013-07-09 | Traditional Chinese medicine for treatment of hyperosteogeny and spondylopathy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103381235B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101564526A (en) * | 2008-04-23 | 2009-10-28 | 焦亮云 | Channel and collateral dredging king |
| CN101683517A (en) * | 2008-09-28 | 2010-03-31 | 马良福 | Plaster for treating neck-shoulder-waist-leg pain and method of preparing same |
| CN102188673A (en) * | 2010-03-17 | 2011-09-21 | 赵贵凤 | Plaster for promoting muscles and bones, and preparation and application thereof |
-
2013
- 2013-07-09 CN CN201310284497.XA patent/CN103381235B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101564526A (en) * | 2008-04-23 | 2009-10-28 | 焦亮云 | Channel and collateral dredging king |
| CN101683517A (en) * | 2008-09-28 | 2010-03-31 | 马良福 | Plaster for treating neck-shoulder-waist-leg pain and method of preparing same |
| CN102188673A (en) * | 2010-03-17 | 2011-09-21 | 赵贵凤 | Plaster for promoting muscles and bones, and preparation and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103381235A (en) | 2013-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1118285C (en) | Shubi plaster for treating arthralgia due to wind-cold-dampness | |
| CN102429956B (en) | External wash and use method thereof | |
| CN102908442B (en) | Composition for treating traumatic injuries and medicinal liquor thereof | |
| CN105125797A (en) | External fumigation medicinal liquor for treating rheumatic arthromyodynia as well as cervical spondylopathy and lumbar spondylosis | |
| CN102178807B (en) | Plaster for treating traumatic injury, pain in neck, waist and lower extremities, and rheumatoid arthritis | |
| CN1362202A (en) | Spur and rheumatism treating plaster | |
| CN101862401B (en) | Chinese medicinal boiled packing bag and method for manufacturing same | |
| CN103393897B (en) | Externally used traditional Chinese medicine for treating hyperostosis and rheumatic ostealgia and preparation method thereof | |
| CN103610774A (en) | External Chinese medicinal composition for treating soft tissue injuries | |
| CN107802814A (en) | Chinese medicine composition and its manufactured plaster and preparation method | |
| CN104491828B (en) | A kind of temperature leads to Traditional Chinese medicine used as analgesic preparation and its paste preparation method | |
| CN103381235B (en) | Traditional Chinese medicine for treatment of hyperosteogeny and spondylopathy | |
| CN103751446B (en) | A kind of Tibetan bee venom plaster treating osteopathia | |
| CN103285345B (en) | Rheumatism osteodynia liniment | |
| CN105998217A (en) | Traditional Chinese medicine composition for treating cervical spondylosis and preparation method | |
| CN104383018A (en) | Lumbar degenerative pathological change treating traditional Chinese medicine composition plaster | |
| CN104225533A (en) | Traditional Chinese medicine composition and preparation method thereof | |
| CN109289020A (en) | Chinese medicine acupoint magnetic heat orients transdermal | |
| CN109125544A (en) | A kind of external application bone-setting ointment and preparation method thereof | |
| CN108686146A (en) | A kind of Dressed plaster promoting blood circulation and removing blood stasis and preparation method thereof | |
| CN108619448A (en) | A kind of plaster and preparation method thereof for treating hyperostosis | |
| CN106924704A (en) | A kind of cervical vertebra plaster formula and its patch preparation method | |
| CN101618200B (en) | Externally-applied plaster for specially treating cervical spondylosis and preparation method thereof | |
| CN106266153A (en) | A kind of for Chinese medicine composition dredging collaterals of human and preparation method thereof | |
| CN104922560B (en) | A kind of joint spirit Chinese medicine composition and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |